Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
Two Years To Go: All Hands Required To Meet DSCSA’s 2023 Deadline
The two-year countdown to the Drug Supply Chain Security Act (DSCSA) deadline has begun. This final milestone, in combination with those already completed, will fundamentally change how product and data move together across the healthcare supply chain.
A Call to Action on EPCIS Adoption for DSCSA
Since the Drug Supply Chain Security Act (DSCSA) was enacted nearly 10 years ago, healthcare supply chain stakeholders have made steady progress in meeting regularly (through HDA and other settings) to discuss compliance strategies, establish recommended guidelines and build consensus on key milestones.
HDA Issues Policy Platform Addressing Drug Shortages
HDA and its pharmaceutical distributor members released a policy agenda to combat drug shortages, centering around three core themes: federal coordination, strategic investment and end-to-end stabilization of the generic drug supply chain.
Rx Supply Chain Progressing on EPCIS Adoption for DSCSA, Yet Challenges Still Remain
Updated survey data released today by the HDA Research Foundation indicate that healthcare supply chain partners remain in the formative stages of establishing the interoperable transaction data connections required to comply with the Drug Supply Chain Security Act (DSCSA) by November 27, 2023. However, some progress has been made since a previous survey conducted last spring.